Vicore Appoints Leading Respiratory Medicine Developer Dr. Bertil Lindmark MD, PhD, as Chief Medical Officer
Vicore Appoints Leading Respiratory Medicine Developer Dr. Bertil Lindmark MD, PhD, as Chief Medical Officer
Source: pharmiweb.com
📰 Clinical Development News
Page 52 - Clinical Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Development. Real-time updates on events, politics, business and more.
Mission Therapeutics moves kidney disease drug to phase 2 after FDA approval
Mission Therapeutics, a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, has received Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) to proceed with a phase 2 trial for its kidney treatment MTX652.
Source: outsourcing-pharma.com
HIV pathology data now reaching investigators within hours
The AIDS and Cancer Specimen (ACSR), a biorepository of specimens collected from persons living with HIV (PLWH) has today (December 12) announced it is using software from Proscia that can provide near real-time access to pathology data to investigators around the world.
Proscia Concentriq David West Paige Bracci National Cancer Institution National Institutes Of Health National Institutes
Source: outsourcing-pharma.com
EPKINLY Market Scenario for DLBCL Treatment through 2032
/PRNewswire/ -- The "EPKINLY Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.coms offering. The report offers detailed...
United States United Kingdom Laura Wood Clinical Development Office Hours Call E St Office Hours Call
Source: prnewswire.com
Pharma-grade cannabis contracts secured by Celadon
Celadon Pharmaceuticals has today (December 14) announced its first supply of it pharmaceutical-grade breakthrough cannabis-based medicine.
United Kingdom James Short Regulatory Agency Celadon Home Office United Kingdom Company United Kingdom Based
Source: outsourcing-pharma.com
QPS Continues UPLCHRMS Expansion Into Europe to Support Gene Therapy and Protein Drug Development
QPS Holdings LLC QPS a global contract research organization CRO that provides discovery preclinical bioanalysis clinical trials and clinical research services is reinforcing its focus on qualitative and quantitative bioanalysis of biotherapeutics in Europe.
United States Daniel Schulz Jander Gabrielle Pastore Technische Universit University Of Kassel Clinical Development
Source: businesswireindia.com
Global Menin Inhibitor Drugs Clinical Trials & Insight
Dublin, Dec. 15, 2023 (GLOBE NEWSWIRE) -- The
Sumitomo Pharma Syndax Pharmaceuticals Clinical Development Daiichi Sankyo Company Bionova Pharmaceuticals Research Methodology
Source: globenewswire.com
United States Zuranolone (SAGE-217) Emerging Drug Insights
Dublin, Dec. 15, 2023 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com
MTG201 + Nivolumab for MPM: Emerging Drug Insights and Market Forecast to 2032
The "MTG201 + nivolumab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.
United States United Kingdom Baylor College Of Medicine Laura Wood E St Office Hours Call Clinical Development
Source: yahoo.com
X0002: An Ibuprofenamine Hydrochloride Spray - Emerging Drug Insights and Market Forecasts to 2032
/PRNewswire/ -- The "X0002 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.coms offering. This report provides...
Source: prnewswire.com